AC Immune SA (ACIU)
NASDAQ
Quarter End | ||||||||
---|---|---|---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | ||||||||
Total Current Assets | ||||||||
Cash and Equivalents | ||||||||
Total Non-Current Assets | ||||||||
Total Liabilities | ||||||||
Total Current Liabilities | ||||||||
Total Non-Current Liabilities | ||||||||
Common Equity | ||||||||
Retained Earnings |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 156.1M | 132.01M | 196.56M | 299.25M | 238.74M | 261.44M | 185.94M | 182.81M |
Total Current Assets | 154.89M | 129.53M | 192.93M | 292.77M | 231.77M | 202.63M | 128.09M | 125.15M |
Cash and Equivalents | 152.21M | 124.38M | 156.46M | 193.59M | 160.89M | 82.22M | 31.59M | 78.49M |
Total Non-Current Assets | 142.38M | 116.84M | 177.62M | 272.44M | 215.48M | 231.98M | 168.99M | 160.64M |
Total Liabilities | 13.72M | 15.17M | 18.93M | 26.81M | 23.26M | 29.46M | 16.95M | 22.17M |
Total Current Liabilities | 9.92M | 9.75M | 13.08M | 17.51M | 14.02M | 20.03M | 11.48M | 13.58M |
Total Non-Current Liabilities | 3.8M | 5.82M | 6.04M | 11.11M | 11.02M | 11.78M | 7.72M | 11.42M |
Total Equity | 142.38M | 116.84M | 177.62M | 272.44M | 215.48M | 231.98M | 168.99M | 160.64M |
Common Equity | 1.14M | 1.15M | 1.35M | 1.44M | 1.54M | 1.79M | 1.8M | 2.09M |
Retained Earnings | -46.92M | -72.61M | -121.88M | -75.52M | -132.85M | -200.94M | -264.02M | -316.2M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.